Acurx Pharmaceuticals, Inc. (ACXP)

Acurx Pharmaceuticals Statistics

Total Valuation

ACXP has a market cap or net worth of $6.83 million. The enterprise value is $766,252.

Market Cap	6.83M
Enterprise Value	766,252

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ACXP has 1.58 million shares outstanding. The number of shares has increased by 32.56% in one year.

Current Share Class	1.58M
Shares Outstanding	1.58M
Shares Change (YoY)	+32.56%
Shares Change (QoQ)	+18.80%
Owned by Insiders (%)	8.12%
Owned by Institutions (%)	6.23%
Float	1.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.78
P/TBV Ratio	1.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.38

Current Ratio	2.38
Quick Ratio	2.36
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -285.93% and return on invested capital (ROIC) is -179.56%.

Return on Equity (ROE)	-285.93%
Return on Assets (ROA)	-98.59%
Return on Invested Capital (ROIC)	-179.56%
Return on Capital Employed (ROCE)	-281.70%
Revenue Per Employee	n/a
Profits Per Employee	-$2.50M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -89.17% in the last 52 weeks. The beta is -1.29, so ACXP's price volatility has been lower than the market average.

Beta (5Y)	-1.29
52-Week Price Change	-89.17%
50-Day Moving Average	6.33
200-Day Moving Average	10.63
Relative Strength Index (RSI)	39.12
Average Volume (20 Days)	73,632

Short Selling Information

The latest short interest is 39,181, so 2.47% of the outstanding shares have been sold short.

Short Interest	39,181
Short Previous Month	36,159
Short % of Shares Out	2.47%
Short % of Float	2.99%
Short Ratio (days to cover)	0.46

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.05M
Pretax Income	-16.73M
Net Income	-10.00M
EBITDA	n/a
EBIT	-10.05M
Earnings Per Share (EPS)	-$10.37

Balance Sheet

The company has $6.06 million in cash and n/a in debt, giving a net cash position of $6.06 million or $3.83 per share.

Cash & Cash Equivalents	6.06M
Total Debt	n/a
Net Cash	6.06M
Net Cash Per Share	$3.83
Equity (Book Value)	3.57M
Book Value Per Share	2.43
Working Capital	3.57M

Cash Flow

Operating Cash Flow	-8.16M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACXP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.56%
Shareholder Yield	n/a
Earnings Yield	-146.39%
FCF Yield	n/a

Analyst Forecast

The average price target for ACXP is $143.67, which is 3,233.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$143.67
Price Target Difference	3,233.41%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 5, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date	Aug 5, 2025
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2